Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders

NeuroMolecular Medicine

Volumn 17, Issue 4, 2015, Pages 404-422

  Carvalho, I M ^a   Coelho, P B ^b   Costa, P C ^a   Marques, C S ^a   Oliveira, R S ^b   Ferreira, D C ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Curcuminoids; Neural stem cells; Neurodegenerative disorders; Neurogenesis; Neurotrophic factors; Retinoic acid

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; AMYLOID BETA PROTEIN; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; FIBROBLAST GROWTH FACTOR; GALANIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NANOPARTICLE; NERVE GROWTH FACTOR; NEUROSTEROID; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR; POLYELECTROLYTE; POLYETHYLENEIMINE DERIVATIVE; PROGESTERONE; RETINOIC ACID; SOMATOMEDIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; NEUROPEPTIDE;

ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; EMBRYONAL TISSUE; EMBRYONIC STEM CELL; FETAL STEM CELL; HUMAN; HYPERBARIC OXYGEN; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NERVE CELL STIMULATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; STRUCTURE ANALYSIS; ADULT; BRAIN; BRAIN TRANSPLANTATION; FETAL TISSUE TRANSPLANTATION; HYPERBARIC OXYGEN THERAPY; INDUCED PLURIPOTENT STEM CELL; MENTAL DISORDERS; NERVE CELL PLASTICITY; NEURAL STEM CELL; NEURODEGENERATIVE DISEASES; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIOXIDANTS; BRAIN; BRAIN TISSUE TRANSPLANTATION; CURCUMIN; EMBRYONIC STEM CELLS; FETAL TISSUE TRANSPLANTATION; HUMANS; HYPERBARIC OXYGENATION; INDUCED PLURIPOTENT STEM CELLS; MENTAL DISORDERS; NERVE GROWTH FACTORS; NEURAL STEM CELLS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; NEUROPEPTIDES; TRETINOIN;

EID: 84947127602     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-015-8369-3     Document Type: Article

References (265)

1. Abakumov, M. A., Shein, S. A., Vishvasrao, H., Nukolova, N. V, Sokol’ski-Papkov, M., Sandalova, T. O., et al. (2012). Visualization of experimental glioma C6 by MRI with magnetic nanoparticles conjugated with monoclonal antibodies to vascular endothelial growth factor. Bulletin of experimental biology and medicine, 154(2), 274–277. http://www.ncbi.nlm.nih.gov/pubmed/23330142. Accessed September 21, 2014.
2. Adachi, M., Barrot, M., Autry, A. E., Theobald, D., & Monteggia, L. M. (2008). Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biological Psychiatry,63(7), 642–649. doi:10.1016/j.biopsych.2007.09.019.
3. Agasse, F., Xapelli, S., Coronas, V., Christiansen, S. H., Rosa, A. I., Sardá-Arroyo, L., et al. (2013). Galanin promotes neuronal differentiation in murine subventricular zone cell cultures. Stem Cells and Development,22(11), 1693–1708. doi:10.1089/scd.2012.0161.
4. Ahmed, Z., Mackenzie, I. R. A., Hutton, M. L., & Dickson, D. W. (2007). Progranulin in frontotemporal lobar degeneration and neuroinflammation. Journal of Neuroinflammation,4, 7. doi:10.1186/1742-2094-4-7.
5. Altman, J. (1962). Are new neurons formed in the brains of adult mammals? Science (New York, N.Y.), 135(3509), 1127–1128. http://www.ncbi.nlm.nih.gov/pubmed/13860748. Accessed June 15, 2014.
6. Altman, J., & Das, G. D. (1965). Post-natal origin of microneurones in the rat brain. Nature, 207(5000), 953–956. http://www.ncbi.nlm.nih.gov/pubmed/5886931. Accessed June 3, 2014.
7. Anacker, C., Zunszain, P. A., Cattaneo, A., Carvalho, L. A., Garabedian, M. J., Thuret, S., et al. (2011). Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Molecular psychiatry,16(7), 738–750. doi:10.1038/mp.2011.26.
8. Anacker, C., Cattaneo, A., Luoni, A., Musaelyan, K., Zunszain, P. A., Milanesi, E., et al. (2013). Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology,38(5), 872–883. doi:10.1038/npp.2012.253.
9. Angelov, B., Angelova, A., Filippov, S. K., Karlsson, G., Terrill, N., Lesieur, S., & Štěpánek, P. (2011). Topology and internal structure of PEGylated lipid nanocarriers for neuronal transfection: synchrotron radiation SAXS and cryo-TEM studies. Soft Matter,7(20), 9714. doi:10.1039/c1sm06447a.
10. Arsenijevic, Y., Villemure, J. G., Brunet, J. F., Bloch, J. J., Déglon, N., Kostic, C., et al. (2001). Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Experimental Neurology,170(1), 48–62. doi:10.1006/exnr.2001.7691.
11. Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., et al. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature,429(6990), 413–417. doi:10.1038/nature02544.
12. Bellamy, V., Vanneaux, V., Bel, A., Nemetalla, H., Emmanuelle Boitard, S., Farouz, Y., et al. (2014). Long-term functional benefits of human embryonic stem cell-derived cardiac progenitors embedded into a fibrin scaffold. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation,. doi:10.1016/j.healun.2014.10.008.
13. Björklund, A., Kirik, D., Rosenblad, C., Georgievska, B., Lundberg, C., & Mandel, R. J. (2000). Towards a neuroprotective gene therapy for Parkinson’s disease: Use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain research, 886(1–2), 82–98. http://www.ncbi.nlm.nih.gov/pubmed/11119690. Accessed June 27, 2014.
14. Bliss, T. M., Kelly, S., Shah, A. K., Foo, W. C., Kohli, P., Stokes, C., et al. (2006). Transplantation of hNT neurons into the ischemic cortex: Cell survival and effect on sensorimotor behavior. Journal of Neuroscience Research,83(6), 1004–1014. doi:10.1002/jnr.20800.
15. Boado, R. J., & Pardridge, W. M. (2011). The Trojan horse liposome technology for nonviral gene transfer across the blood-brain barrier. Journal of Drug Delivery,2011, 296151. doi:10.1155/2011/296151.
16. Bohl, D., Liu, S., Blanchard, S., Hocquemiller, M., Haase, G., & Heard, J.-M. (2008). Directed evolution of motor neurons from genetically engineered neural precursors. Stem Cells (Dayton, Ohio),26(10), 2564–2575. doi:10.1634/stemcells.2008-0371.
17. Boido, M., Rupa, R., Garbossa, D., Fontanella, M., Ducati, A., & Vercelli, A. (2009). Embryonic and adult stem cells promote raphespinal axon outgrowth and improve functional outcome following spinal hemisection in mice. The European journal of neuroscience,30(5), 833–846. doi:10.1111/j.1460-9568.2009.06879.x.
18. Bolognin, S., Buffelli, M., Puoliväli, J., & Iqbal, K. (2014). Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. Neurobiology of Aging,. doi:10.1016/j.neurobiolaging.2014.02.017.
19. Bonhomme, D., Minni, A. M., Alfos, S., Roux, P., Richard, E., Higueret, P., et al. (2014). Vitamin A status regulates glucocorticoid availability in Wistar rats: Consequences on cognitive functions and hippocampal neurogenesis? Frontiers in Behavioral Neuroscience,8, 20. doi:10.3389/fnbeh.2014.00020.
20. Bothwell, M. (1995). Functional interactions of neurotrophins and neurotrophin receptors. Annual Review of Neuroscience,18, 223–253. doi:10.1146/annurev.ne.18.030195.001255.
21. Brinton, R. D., & Wang, J. M. (2006a). Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer’s disease: Allopregnanolone as a proof of concept neurogenic agent. Current Alzheimer Research, 3(3), 185–190. http://www.ncbi.nlm.nih.gov/pubmed/16842093. Accessed June 5, 2014.
22. Brinton, R. D., & Wang, J. M. (2006b). Preclinical analyses of the therapeutic potential of allopregnanolone to promote neurogenesis in vitro and in vivo in transgenic mouse model of Alzheimer’s disease. Current Alzheimer Research, 3(1), 11–17. http://www.ncbi.nlm.nih.gov/pubmed/16472197. Accessed July 15, 2014.
23. Bristot, G., Ascoli, B., Gubert, C., Panizzutti, B., Kapczinski, F., & Rosa, A. R. (2014). Progesterone and its metabolites as therapeutic targets in psychiatric disorders. Expert Opinion on Therapeutic Targets,18(6), 679–690. doi:10.1517/14728222.2014.897329.
24. Brossaud, J., Roumes, H., Moisan, M.-P., Pallet, V., Redonnet, A., & Corcuff, J.-B. (2013). Retinoids and glucocorticoids target common genes in hippocampal HT22 cells. Journal of Neurochemistry,125(4), 518–531. doi:10.1111/jnc.12192.
25. Bruno, M. A., & Cuello, A. C. (2006). Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade. Proceedings of the National Academy of Sciences of the United States of America,103(17), 6735–6740. doi:10.1073/pnas.0510645103.
26. Cai, J., Hua, F., Yuan, L., Tang, W., Lu, J., Yu, S., et al. (2014). Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases. BioMed Research International,2014, 601084. doi:10.1155/2014/601084.
27. Calza, L., Giuliani, A., Fernandez, M., Pirondi, S., D’Intino, G., Aloe, L., & Giardino, L. (2003). Neural stem cells and cholinergic neurons: regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor. Proceedings of the National Academy of Sciences of the United States of America,100(12), 7325–7330. doi:10.1073/pnas.1132092100.
28. Cameron, H. A., & Gould, E. (1994). Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience, 61(2), 203–209. http://www.ncbi.nlm.nih.gov/pubmed/7969902. Accessed June 17, 2014.
29. Canales, J. J. (2007). Adult neurogenesis and the memories of drug addiction. European Archives of Psychiatry and Clinical Neuroscience,257(5), 261–270. doi:10.1007/s00406-007-0730-6.
30. Capetian, P., Knoth, R., Maciaczyk, J., Pantazis, G., Ditter, M., Bokla, L., et al. (2009). Histological findings on fetal striatal grafts in a Huntington’s disease patient early after transplantation. Neuroscience,160(3), 661–675. doi:10.1016/j.neuroscience.2009.02.035.
31. Caravagna, C., Soliz, J., & Seaborn, T. (2013). Brain-derived neurotrophic factor interacts with astrocytes and neurons to control respiration. The European Journal of Neuroscience,38(9), 3261–3269. doi:10.1111/ejn.12320.
32. Carpenter, M. K., Inokuma, M. S., Denham, J., Mujtaba, T., Chiu, C. P., & Rao, M. S. (2001). Enrichment of neurons and neural precursors from human embryonic stem cells. Experimental Neurology,172(2), 383–397. doi:10.1006/exnr.2001.7832.
33. Castrén, E., & Tanila, H. (2006). Neurotrophins and dementia–keeping in touch. Neuron,51(1), 1–3. doi:10.1016/j.neuron.2006.06.019.
34. Cattaneo, E., Zuccato, C., & Tartari, M. (2005). Normal huntingtin function: An alternative approach to Huntington’s disease. Nature Reviews Neuroscience,6(12), 919–930. doi:10.1038/nrn1806.
35. Chaddah, R., Arntfield, M., Runciman, S., Clarke, L., & van der Kooy, D. (2012). Clonal neural stem cells from human embryonic stem cell colonies. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,32(23), 7771–7781. doi:10.1523/JNEUROSCI.3286-11.2012.
36. Chao, M. V. (2003). Neurotrophins and their receptors: a convergence point for many signalling pathways. Nature Reviews Neuroscience,4(4), 299–309. doi:10.1038/nrn1078.
37. Chen, W., Jongkamonwiwat, N., Abbas, L., Eshtan, S. J., Johnson, S. L., Kuhn, S., et al. (2012). Restoration of auditory evoked responses by human ES-cell-derived otic progenitors. Nature,490(7419), 278–282. doi:10.1038/nature11415.
38. Chiu, S., Terpstra, K. J., Bureau, Y., Hou, J., Raheb, H., Cernvosky, Z., et al. (2013). Liposomal-formulated curcumin [Lipocurc™] targeting HDAC (histone deacetylase) prevents apoptosis and improves motor deficits in Park 7 (DJ-1)-knockout rat model of Parkinson’s disease: implications for epigenetics-based nanotechnology-driven drug platform. Journal of Complementary & Integrative Medicine,. doi:10.1515/jcim-2013-0020.
39. Cho, M. S., Lee, Y.-E., Kim, J. Y., Chung, S., Cho, Y. H., Kim, D.-S., et al. (2008). Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America,105(9), 3392–3397. doi:10.1073/pnas.0712359105.
40. Choi-Lundberg, D. L., Lin, Q., Chang, Y. N., Chiang, Y. L., Hay, C. M., Mohajeri, H., et al. (1997). Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science (New York, N.Y.), 275(5301), 838–841. http://www.ncbi.nlm.nih.gov/pubmed/9012352. Accessed June 5, 2014.
41. Chong, J. J. H., Yang, X., Don, C. W., Minami, E., Liu, Y.-W., Weyers, J. J., et al. (2014). Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature,510(7504), 273–277. doi:10.1038/nature13233.
42. Chung, C.-Y., Yang, J.-T., & Kuo, Y.-C. (2013). Polybutylcyanoacrylate nanoparticles for delivering hormone response element-conjugated neurotrophin-3 to the brain of intracerebral hemorrhagic rats. Biomaterials,34(37), 9717–9727. doi:10.1016/j.biomaterials.2013.08.083.
43. Connor, B., Young, D., Yan, Q., Faull, R. L., Synek, B., & Dragunow, M. (1997). Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Brain Research Molecular Brain Research, 49(1–2), 71–81. http://www.ncbi.nlm.nih.gov/pubmed/9387865. Accessed July 6, 2014.
44. Conti, L., Cataudella, T., & Cattaneo, E. (2003). Neural stem cells: a pharmacological tool for brain diseases? Pharmacological Research: The Official Journal of the Italian Pharmacological Society, 47(4), 289–297. http://www.ncbi.nlm.nih.gov/pubmed/12644385. Accessed June 28, 2014.
45. Corcoran, J., & Maden, M. (1999). Nerve growth factor acts via retinoic acid synthesis to stimulate neurite outgrowth. Nature Neuroscience,2(4), 307–308. doi:10.1038/7214.
46. Cowansage, K. K., LeDoux, J. E., & Monfils, M.-H. (2010). Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Current Molecular Pharmacology, 3(1), 12–29. http://www.ncbi.nlm.nih.gov/pubmed/20030625. Accessed July 7, 2014.
47. Crews, F. T., & Nixon, K. (2003). Alcohol, neural stem cells, and adult neurogenesis. Alcohol Research & Health: The Journal of the National Institute on Alcohol Abuse and Alcoholism, 27(2), 197–204. http://www.ncbi.nlm.nih.gov/pubmed/15303631. Accessed June 28, 2014.
48. Croce, N., Mathé, A. A., Gelfo, F., Caltagirone, C., Bernardini, S., & Angelucci, F. (2014). Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration. Journal of Psychopharmacology (Oxford, England),. doi:10.1177/0269881114529379.
49. Cuello, A. C., & Bruno, M. A. (2007). The failure in NGF maturation and its increased degradation as the probable cause for the vulnerability of cholinergic neurons in Alzheimer’s disease. Neurochemical Research,32(6), 1041–1045. doi:10.1007/s11064-006-9270-0.
50. Curtis, M. A., Penney, E. B., Pearson, A. G., van Roon-Mom, W. M. C., Butterworth, N. J., Dragunow, M., et al. (2003). Increased cell proliferation and neurogenesis in the adult human Huntington’s disease brain. Proceedings of the National Academy of Sciences of the United States of America,100(15), 9023–9027. doi:10.1073/pnas.1532244100.
51. Curtis, M. A., Kam, M., Nannmark, U., Anderson, M. F., Axell, M. Z., Wikkelso, C., et al. (2007). Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science (New York, N.Y.),315(5816), 1243–1249. doi:10.1126/science.1136281.
52. D’Amour, K. A., Bang, A. G., Eliazer, S., Kelly, O. G., Agulnick, A. D., Smart, N. G., et al. (2006). Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnology,24(11), 1392–1401. doi:10.1038/nbt1259.
53. DeCarolis, N. A., & Eisch, A. J. (2010). Hippocampal neurogenesis as a target for the treatment of mental illness: A critical evaluation. Neuropharmacology,58(6), 884–893. doi:10.1016/j.neuropharm.2009.12.013.
54. Dodge, J. C., Haidet, A. M., Yang, W., Passini, M. A., Hester, M., Clarke, J., et al. (2008). Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Molecular Therapy: The Journal of the American Society of Gene Therapy,16(6), 1056–1064. doi:10.1038/mt.2008.60.
55. Doetsch, F., & Alvarez-Buylla, A. (1996). Network of tangential pathways for neuronal migration in adult mammalian brain. Proceedings of the National Academy of Sciences of the United States of America, 93(25), 14895–14900. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=26233&tool=pmcentrez&rendertype=abstract. Accessed June 15, 2014.
56. Doi, D., Samata, B., Katsukawa, M., Kikuchi, T., Morizane, A., Ono, Y., et al. (2014). Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports,2(3), 337–350. doi:10.1016/j.stemcr.2014.01.013.
57. Dorsey, S. G., Renn, C. L., Carim-Todd, L., Barrick, C. A., Bambrick, L., Krueger, B. K., et al. (2006). In vivo restoration of physiological levels of truncated Trk.BT1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron,51(1), 21–28. doi:10.1016/j.neuron.2006.06.009.
58. Drinkut, A., Tereshchenko, Y., Schulz, J. B., Bähr, M., & Kügler, S. (2012). Efficient gene therapy for Parkinson’s disease using astrocytes as hosts for localized neurotrophic factor delivery. Molecular Therapy: The Journal of the American Society of Gene Therapy,20(3), 534–543. doi:10.1038/mt.2011.249.
59. Duman, R. S., Malberg, J., & Nakagawa, S. (2001). Regulation of adult neurogenesis by psychotropic drugs and stress. The Journal of Pharmacology and Experimental Therapeutics, 299(2), 401–407. http://www.ncbi.nlm.nih.gov/pubmed/11602648. Accessed June 28, 2014.
60. Duman, R. S., Nakagawa, S., & Malberg, J. (2001b). Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology,25(6), 836–844. doi:10.1016/S0893-133X(01)00358-X.
61. Dwivedi, Y. (2009). Brain-derived neurotrophic factor: Role in depression and suicide. Neuropsychiatric Disease and Treatment, 5, 433–449. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2732010&tool=pmcentrez&rendertype=abstract. Accessed June 5, 2014.
62. Eggert, K., Schlegel, J., Oertel, W., Würz, C., Krieg, J. C., & Vedder, H. (1999). Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Neuroscience Letters, 269(3), 178–182. http://www.ncbi.nlm.nih.gov/pubmed/10454161. Accessed July 4, 2014.
63. Eisch, A. J., Barrot, M., Schad, C. A., Self, D. W., & Nestler, E. J. (2000). Opiates inhibit neurogenesis in the adult rat hippocampus. Proceedings of the National Academy of Sciences of the United States of America,97(13), 7579–7584. doi:10.1073/pnas.120552597.
64. Eisch, A. J., Cameron, H. A., Encinas, J. M., Meltzer, L. A., Ming, G.-L., & Overstreet-Wadiche, L. S. (2008). Adult neurogenesis, mental health, and mental illness: Hope or hype? The Journal of Neuroscience: the Official Journal of the Society for Neuroscience,28(46), 11785–11791. doi:10.1523/JNEUROSCI.3798-08.2008.
65. Elizalde, C., Campa, V. M., Caro, M., Schlangen, K., Aransay, A. M., Vivanco, M. dM, & Kypta, R. M. (2011). Distinct roles for Wnt-4 and Wnt-11 during retinoic acid-induced neuronal differentiation. Stem cells (Dayton, Ohio), 29(1), 141–153. doi:10.1002/stem.562.
66. Erceg, S., Ronaghi, M., Oria, M., Roselló, M. G., Aragó, M. A. P., Lopez, M. G., et al. (2010). Transplanted oligodendrocytes and motoneuron progenitors generated from human embryonic stem cells promote locomotor recovery after spinal cord transection. Stem cells (Dayton, Ohio), 28(9), 1541–1549. doi:10.1002/stem.489.
67. Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998). Neurogenesis in the adult human hippocampus. Nature Medicine,4(11), 1313–1317. doi:10.1038/3305.
68. Eslamboli, A., Georgievska, B., Ridley, R. M., Baker, H. F., Muzyczka, N., Burger, C., et al. (2005). Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,25(4), 769–777. doi:10.1523/JNEUROSCI.4421-04.2005.
69. Fischer, W., Wictorin, K., Björklund, A., Williams, L. R., Varon, S., & Gage, F. H. (1987). Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature,329(6134), 65–68. doi:10.1038/329065a0.
70. Frank, L., Ventimiglia, R., Anderson, K., Lindsay, R. M., & Rudge, J. S. (1996). BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons. The European Journal of Neuroscience, 8(6), 1220–1230. http://www.ncbi.nlm.nih.gov/pubmed/8752592. Accessed September 14, 2014.
71. Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W. Y., DuMouchel, W., Kao, R., et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. The New England Journal of Medicine,344(10), 710–719. doi:10.1056/NEJM200103083441002.
72. Fuchs, E., & Flügge, G. (2014). Adult neuroplasticity: More than 40 years of research. Neural Plasticity,. doi:10.1155/2014/541870.
73. Fukuda, Y., Berry, T. L., Nelson, M., Hunter, C. L., Fukuhara, K., Imai, H., et al. (2010). Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin. Molecular and Cellular Neurosciences,45(3), 226–233. doi:10.1016/j.mcn.2010.06.013.
74. Gage, F. H. (2000). Mammalian neural stem cells. Science (New York, N.Y.), 287(5457), 1433–1438. http://www.ncbi.nlm.nih.gov/pubmed/10688783. Accessed June 2, 2014.
75. Gaillard, A., Prestoz, L., Dumartin, B., Cantereau, A., Morel, F., Roger, M., & Jaber, M. (2007). Reestablishment of damaged adult motor pathways by grafted embryonic cortical neurons. Nature Neuroscience,10(10), 1294–1299. doi:10.1038/nn1970.
76. Garcia-Alloza, M., Borrelli, L. A., Rozkalne, A., Hyman, B. T., & Bacskai, B. J. (2007). Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. Journal of Neurochemistry,102(4), 1095–1104. doi:10.1111/j.1471-4159.2007.04613.x.
77. Géral, C., Angelova, A., Angelov, B., Nicolas, V., & Lesieur, S. (2012). Multicompartment lipid nanocarriers for targeting of cells expressing brain receptors. In N. Garti, R. Mezzenga, & P. Somasundaran (Eds.), Self-assembled supramolecular architectures: Lyotropic liquid crystals (pp. 319–355). New York, USA: Wiley.
78. Géral, C., Angelova, A., & Lesieur, S. (2013). From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF). Pharmaceutics,5(1), 127–167. doi:10.3390/pharmaceutics5010127.
79. Gerrard, L., Rodgers, L., & Cui, W. (2005). Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells (Dayton, Ohio),23(9), 1234–1241. doi:10.1634/stemcells.2005-0110.
80. Godman, C. A., Joshi, R., Giardina, C., Perdrizet, G., & Hightower, L. E. (2010). Hyperbaric oxygen treatment induces antioxidant gene expression. Annals of the New York Academy of Sciences,1197, 178–183. doi:10.1111/j.1749-6632.2009.05393.x.
81. Gonzalez, S. L., Labombarda, F., Deniselle, M. C. G., Mougel, A., Guennoun, R., Schumacher, M., & De Nicola, A. F. (2005). Progesterone neuroprotection in spinal cord trauma involves up-regulation of brain-derived neurotrophic factor in motoneurons. The Journal of Steroid Biochemistry and Molecular Biology,94(1–3), 143–149. doi:10.1016/j.jsbmb.2005.01.016.
82. Grandoso, L., Ponce, S., Manuel, I., Arrúe, A., Ruiz-Ortega, J. A., Ulibarri, I., et al. (2007). Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. International Journal of Pharmaceutics,343(1–2), 69–78. doi:10.1016/j.ijpharm.2007.05.027.
83. Grealish, S., Diguet, E., Kirkeby, A., Mattsson, B., Heuer, A., Bramoulle, Y., et al. (2014). Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson’s Disease. Cell Stem Cell,15(5), 653–665. doi:10.1016/j.stem.2014.09.017.
84. Grondin, R., Zhang, Z., Yi, A., Cass, W. A., Maswood, N., Andersen, A. H., et al. (2002). Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain: Journal of Neurology, 125(Pt 10), 2191–2201. http://www.ncbi.nlm.nih.gov/pubmed/12244077. Accessed June 5, 2014.
85. Grondin, R., Zhang, Z., Ai, Y., Gash, D. M., & Gerhardt, G. A. (2003). Intracranial delivery of proteins and peptides as a therapy for neurodegenerative diseases. Progress in drug research. Fortschritte der Arzneimittelforschung. Progrès des recherches pharmaceutiques, 61, 101–123. http://www.ncbi.nlm.nih.gov/pubmed/14674610. Accessed July 8, 2014.
86. Günther, A., Küppers-Tiedt, L., Schneider, P.-M., Kunert, I., Berrouschot, J., Schneider, D., & Rossner, S. (2005). Reduced infarct volume and differential effects on glial cell activation after hyperbaric oxygen treatment in rat permanent focal cerebral ischaemia. The European Journal of Neuroscience,21(11), 3189–3194. doi:10.1111/j.1460-9568.2005.04151.x.
87. Hádinger, N., Varga, B. V., Berzsenyi, S., Környei, Z., Madarász, E., & Herberth, B. (2009). Astroglia genesis in vitro: Distinct effects of retinoic acid in different phases of neural stem cell differentiation. International Journal of Developmental Neuroscience: The Official Journal of the International Society for Developmental Neuroscience,27(4), 365–375. doi:10.1016/j.ijdevneu.2009.02.004.
88. Hanson, N. D., Nemeroff, C. B., & Owens, M. J. (2011). Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist R121919, increases cell proliferation in the adult dentate gyrus. The Journal of Pharmacology and Experimental Therapeutics,337(1), 180–186. doi:10.1124/jpet.110.175372.
89. Harwood, A. J. (2003). Neurodevelopment and mood stabilizers. Current Molecular Medicine, 3(5), 472–482. http://www.ncbi.nlm.nih.gov/pubmed/12943000. Accessed June 28, 2014.
90. Haskell, G. T., & LaMantia, A.-S. (2005). Retinoic acid signaling identifies a distinct precursor population in the developing and adult forebrain. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,25(33), 7636–7647. doi:10.1523/JNEUROSCI.0485-05.2005.
91. He, J., Evans, C.-O., Hoffman, S. W., Oyesiku, N. M., & Stein, D. G. (2004). Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Experimental Neurology,189(2), 404–412. doi:10.1016/j.expneurol.2004.06.008.
92. Herrán, E., Pérez-González, R., Igartua, M., Pedraz, J. L., Carro, E., & Hernández, R. M. (2013). VEGF-releasing biodegradable nanospheres administered by craniotomy: A novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer’s disease. Journal of Controlled Release: Official Journal of the Controlled Release Society,170(1), 111–119. doi:10.1016/j.jconrel.2013.04.028.
93. Herrán, E., Requejo, C., Ruiz-Ortega, J. A., Aristieta, A., Igartua, M., Bengoetxea, H., et al. (2014). Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson’s disease. International Journal of Nanomedicine,9(Suppl 1), 2677–2687. doi:10.2147/IJN.S61940.
94. Hester, M. E., Murtha, M. J., Song, S., Rao, M., Miranda, C. J., Meyer, K., et al. (2011). Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Molecular Therapy: The Journal of the American Society of Gene Therapy,19(10), 1905–1912. doi:10.1038/mt.2011.135.
95. Hicks, A. U., Lappalainen, R. S., Narkilahti, S., Suuronen, R., Corbett, D., Sivenius, J., et al. (2009). Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: Cell survival and functional recovery. The European Journal of Neuroscience,29(3), 562–574. doi:10.1111/j.1460-9568.2008.06599.x.
96. Huang, H.-C., Lin, C.-J., Liu, W.-J., Jiang, R.-R., & Jiang, Z.-F. (2011). Dual effects of curcumin on neuronal oxidative stress in the presence of Cu(II). Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association,49(7), 1578–1583. doi:10.1016/j.fct.2011.04.004.
97. Inestrosa, N. C., & Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nature Reviews Neuroscience,11(2), 77–86. doi:10.1038/nrn2755.
98. Itsykson, P., Ilouz, N., Turetsky, T., Goldstein, R. S., Pera, M. F., Fishbein, I., et al. (2005). Derivation of neural precursors from human embryonic stem cells in the presence of noggin. Molecular and Cellular Neurosciences,30(1), 24–36. doi:10.1016/j.mcn.2005.05.004.
99. Jacobs, S., Lie, D. C., DeCicco, K. L., Shi, Y., DeLuca, L. M., Gage, F. H., & Evans, R. M. (2006). Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proceedings of the National Academy of Sciences of the United States of America,103(10), 3902–3907. doi:10.1073/pnas.0511294103.
100. Jagasia, R., Steib, K., Englberger, E., Herold, S., Faus-Kessler, T., Saxe, M., et al. (2009). GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,29(25), 7966–7977. doi:10.1523/JNEUROSCI.1054-09.2009.
101. Je, H. S., Yang, F., Ji, Y., Potluri, S., Fu, X.-Q., Luo, Z.-G., et al. (2013). ProBDNF and mature BDNF as punishment and reward signals for synapse elimination at mouse neuromuscular junctions. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,33(24), 9957–9962. doi:10.1523/JNEUROSCI.0163-13.2013.
102. Jepson, B., Granpeesheh, D., Tarbox, J., Olive, M. L., Stott, C., Braud, S., et al. (2011). Controlled evaluation of the effects of hyperbaric oxygen therapy on the behavior of 16 children with autism spectrum disorders. Journal of Autism and Developmental Disorders,41(5), 575–588. doi:10.1007/s10803-010-1075-y.
103. Johansson, A. G. M., Nikamo, P., Schalling, M., & Landén, M. (2011). AKR1C4 gene variant associated with low euthymic serum progesterone and a history of mood irritability in males with bipolar disorder. Journal of Affective Disorders,133(1–2), 346–351. doi:10.1016/j.jad.2011.04.009.
104. Kaplan, D. R., Hempstead, B. L., Martin-Zanca, D., Chao, M. V, & Parada, L. F. (1991). The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (New York, N.Y.), 252(5005), 554–558. http://www.ncbi.nlm.nih.gov/pubmed/1850549. Accessed June 29, 2014.
105. Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science (New York, N.Y.),301(5634), 839–842. doi:10.1126/science.1086137.
106. Katz, D. M. (2014). Brain-derived neurotrophic factor and Rett syndrome. Handbook of Experimental Pharmacology,220, 481–495. doi:10.1007/978-3-642-45106-5_18.
107. Kawamata, T., Dietrich, W. D., Schallert, T., Gotts, J. E., Cocke, R. R., Benowitz, L. I., & Finklestein, S. P. (1997). Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proceedings of the National Academy of Sciences of the United States of America, 94(15), 8179–8184. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=21577&tool=pmcentrez&rendertype=abstract. Accessed June 30, 2014.
108. Kells, A. P., Eberling, J., Su, X., Pivirotto, P., Bringas, J., Hadaczek, P., et al. (2010). Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,30(28), 9567–9577. doi:10.1523/JNEUROSCI.0942-10.2010.
109. Kelly, O. G., Chan, M. Y., Martinson, L. A., Kadoya, K., Ostertag, T. M., Ross, K. G., et al. (2011). Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nature Biotechnology,29(8), 750–756. doi:10.1038/nbt.1931.
110. Kempermann, G., Krebs, J., & Fabel, K. (2008). The contribution of failing adult hippocampal neurogenesis to psychiatric disorders. Current Opinion in Psychiatry,21(3), 290–295. doi:10.1097/YCO.0b013e3282fad375.
111. Kernie, S. G., & Parent, J. M. (2010). Forebrain neurogenesis after focal Ischemic and traumatic brain injury. Neurobiology of Disease,37(2), 267–274. doi:10.1016/j.nbd.2009.11.002.
112. Kim, D. S., Park, S. Y., & Kim, J. K. (2001). Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neuroscience Letters, 303(1), 57–61. http://www.ncbi.nlm.nih.gov/pubmed/11297823. Accessed July 29, 2014.
113. Kim, J.-H., Auerbach, J. M., Rodríguez-Gómez, J. A., Velasco, I., Gavin, D., Lumelsky, N., et al. (2002). Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson’s disease. Nature,418(6893), 50–56. doi:10.1038/nature00900.
114. Kim, M., Lee, S.-T., Chu, K., & Kim, S. U. (2008a). Stem cell-based cell therapy for Huntington disease: A review. Neuropathology: Official Journal of the Japanese Society of Neuropathology,28(1), 1–9. doi:10.1111/j.1440-1789.2007.00858.x.
115. Kim, S. J., Son, T. G., Park, H. R., Park, M., Kim, M.-S., Kim, H. S., et al. (2008b). Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. The Journal of biological chemistry,283(21), 14497–14505. doi:10.1074/jbc.M708373200.
116. Kimbrel, E. A., & Lanza, R. (2015). Hope for regenerative treatments: Toward safe transplantation of human pluripotent stem-cell-based therapies. Regenerative Medicine,10(2), 99–102. doi:10.2217/rme.14.89.
117. Klein, R., Jing, S. Q., Nanduri, V., O’Rourke, E., & Barbacid, M. (1991a). The trk proto-oncogene encodes a receptor for nerve growth factor. Cell, 65(1), 189–197. http://www.ncbi.nlm.nih.gov/pubmed/1849459. Accessed June 29, 2014.
118. Klein, R., Nanduri, V., Jing, S. A., Lamballe, F., Tapley, P., Bryant, S., et al. (1991b). The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell, 66(2), 395–403. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2710095&tool=pmcentrez&rendertype=abstract. Accessed June 29, 2014.
119. Knusel, B., Gao, H., Okazaki, T., Yoshida, T., Mori, N., Hefti, F., & Kaplan, D. R. (1997). Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons. Neuroscience, 78(3), 851–862. http://www.ncbi.nlm.nih.gov/pubmed/9153663. Accessed September 14, 2014.
120. Koch, P., Opitz, T., Steinbeck, J. A., Ladewig, J., & Brüstle, O. (2009). A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proceedings of the National Academy of Sciences of the United States of America,106(9), 3225–3230. doi:10.1073/pnas.0808387106.
121. Krencik, R., Weick, J. P., Liu, Y., Zhang, Z.-J., & Zhang, S.-C. (2011). Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nature Biotechnology,29(6), 528–534. doi:10.1038/nbt.1877.
122. Ku, B., Kim, J., Chung, B. H., & Chung, B. G. (2013). Retinoic acid-polyethyleneimine complex nanoparticles for embryonic stem cell-derived neuronal differentiation. Langmuir: The ACS Journal of Surfaces and Colloids,29(31), 9857–9862. doi:10.1021/la4015543.
123. Kuhn, H. G., Palmer, T. D., & Fuchs, E. (2001). Adult neurogenesis: compensatory mechanism for neuronal damage. European Archives of Psychiatry and Clinical Neuroscience, 251(4), 152–158. http://www.ncbi.nlm.nih.gov/pubmed/11697579. Accessed June 28, 2014.
124. Kukekov, V. G., Laywell, E. D., Suslov, O., Davies, K., Scheffler, B., Thomas, L. B., et al. (1999). Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Experimental Neurology,156(2), 333–344. doi:10.1006/exnr.1999.7028.
125. Kurakhmaeva, K. B., Djindjikhashvili, I. A., Petrov, V. E., Balabanyan, V. U., Voronina, T. A., Trofimov, S. S., et al. (2009). Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles. Journal of Drug Targeting,17(8), 564–574. doi:10.1080/10611860903112842.
126. Lamballe, F., Klein, R., & Barbacid, M. (1991). trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell,66(5), 967–979. doi:10.1016/0092-8674(91)90442-2.
127. Lamm, O., Ganz, J., Melamed, E., & Offen, D. (2014). Harnessing neurogenesis for the possible treatment of Parkinson’s disease. The Journal of Comparative Neurology,. doi:10.1002/cne.23607.
128. Lee, G., Kim, H., Elkabetz, Y., Al Shamy, G., Panagiotakos, G., Barberi, T., et al. (2007a). Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nature Biotechnology,25(12), 1468–1475. doi:10.1038/nbt1365.
129. Lee, H., Shamy, G. Al, Elkabetz, Y., Schofield, C. M., Harrsion, N. L., Panagiotakos, G., et al. (2007b). Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells (Dayton, Ohio),25(8), 1931–1939. doi:10.1634/stemcells.2007-0097.
130. Lee, Y.-C., Chio, C.-C., Chang, C.-P., Wang, L.-C., Chiang, P.-M., Niu, K.-C., & Tsai, K.-J. (2013). Long course hyperbaric oxygen stimulates neurogenesis and attenuates inflammation after ischemic stroke. Inflammatory Mediators,2013, 13.
131. Leonard, B. W., Mastroeni, D., Grover, A., Liu, Q., Yang, K., Gao, M., et al. (2009). Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease. The Journal of Comparative Neurology,515(3), 269–294. doi:10.1002/cne.22040.
132. Lepski, G. (2012). What do we know about the neurogenic potential of different stem cell types? Arquivos de Neuro-Psiquiatria,70(7), 540–546. doi:10.1590/S0004-282X2012000700013.
133. Levin, H. S. (2003). Neuroplasticity following non-penetrating traumatic brain injury. Brain Injury: [BI],17(8), 665–674. doi:10.1080/0269905031000107151.
134. Liebau, S., Vaida, B., Storch, A., & Boeckers, T. M. (2007). Maturation of synaptic contacts in differentiating neural stem cells. Stem cells (Dayton, Ohio),25(7), 1720–1729. doi:10.1634/stemcells.2006-0823.
135. Lindvall, O., & Wahlberg, L. U. (2008). Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson’s disease? Experimental Neurology,209(1), 82–88. doi:10.1016/j.expneurol.2007.08.019.
136. Liu, Z., & Holmes, G. L. (1997). Basic fibroblast growth factor is highly neuroprotective against seizure-induced long-term behavioural deficits. Neuroscience, 76(4), 1129–1138. http://www.ncbi.nlm.nih.gov/pubmed/9027873. Accessed June 30, 2014.
137. Liu, D., Wang, Z., Gao, Z., Xie, K., Zhang, Q., Jiang, H., & Pang, Q. (2014). Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress. Behavioural Brain Research,271C, 116–121. doi:10.1016/j.bbr.2014.05.068.
138. Lois, C., García-Verdugo, J. M., & Alvarez-Buylla, A. (1996). Chain migration of neuronal precursors. Science (New York, N.Y.), 271(5251), 978–981. http://www.ncbi.nlm.nih.gov/pubmed/8584933. Accessed June 15, 2014.
139. Lovell, M. A., Geiger, H., Van Zant, G. E., Lynn, B. C., & Markesbery, W. R. (2006). Isolation of neural precursor cells from Alzheimer’s disease and aged control postmortem brain. Neurobiology of Aging,27(7), 909–917. doi:10.1016/j.neurobiolaging.2005.05.004.
140. Lu, P., Jones, L. L., Snyder, E. Y., & Tuszynski, M. H. (2003). Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Experimental Neurology, 181(2), 115–129. http://www.ncbi.nlm.nih.gov/pubmed/12781986. Accessed May 31, 2014.
141. Lu, J., Tan, L., Li, P., Gao, H., Fang, B., Ye, S., et al. (2009). All-trans retinoic acid promotes neural lineage entry by pluripotent embryonic stem cells via multiple pathways. BMC Cell Biology,10, 57. doi:10.1186/1471-2121-10-57.
142. Ma, Y.-P., Ma, M.-M., Cheng, S.-M., Ma, H.-H., Yi, X.-M., Xu, G.-L., & Liu, X.-F. (2008). Intranasal bFGF-induced progenitor cell proliferation and neuroprotection after transient focal cerebral ischemia. Neuroscience Letters,437(2), 93–97. doi:10.1016/j.neulet.2008.04.003.
143. Macas, J., Nern, C., Plate, K. H., & Momma, S. (2006). Increased generation of neuronal progenitors after ischemic injury in the aged adult human forebrain. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,26(50), 13114–13119. doi:10.1523/JNEUROSCI.4667-06.2006.
144. Maia, J., Santos, T., Aday, S., Agasse, F., Cortes, L., Malva, J. O., et al. (2011). Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles. ACS Nano,5(1), 97–106. doi:10.1021/nn101724r.
145. Malberg, J. E. (2004). Implications of adult hippocampal neurogenesis in antidepressant action. Journal of Psychiatry & Neuroscience: PN, 29(3), 196–205. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=400689&tool=pmcentrez&rendertype=abstract. Accessed June 28, 2014.
146. Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 20(24), 9104–9110. http://www.ncbi.nlm.nih.gov/pubmed/11124987. Accessed June 13, 2014.
147. Mansouri, Z., Sabetkasaei, M., Moradi, F., Masoudnia, F., & Ataie, A. (2012). Curcumin has neuroprotection effect on homocysteine rat model of Parkinson. Journal of Molecular Neuroscience: MN,47(2), 234–242. doi:10.1007/s12031-012-9727-3.
148. Marlatt, M. W., Lucassen, P. J., & van Praag, H. (2010). Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. Brain Research,1341, 93–99. doi:10.1016/j.brainres.2010.03.086.
149. Martina, M.-S., Wilhelm, C., & Lesieur, S. (2008). The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells. Biomaterials,29(30), 4137–4145. doi:10.1016/j.biomaterials.2008.07.011.
150. Martinez-Fong, D., Bannon, M. J., Trudeau, L.-E., Gonzalez-Barrios, J. A., Arango-Rodriguez, M. L., Hernandez-Chan, N. G., et al. (2012). NTS-Polyplex: A potential nanocarrier for neurotrophic therapy of Parkinson’s disease. Nanomedicine: Nanotechnology, Biology and Medicine,8(7), 1052–1069. doi:10.1016/j.nano.2012.02.009.
151. Marx, C. E., VanDoren, M. J., Duncan, G. E., Lieberman, J. A., & Morrow, A. L. (2003). Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology,28(1), 1–13. doi:10.1038/sj.npp.1300015.
152. Mattson, M. P. (2008). Glutamate and neurotrophic factors in neuronal plasticity and disease. Annals of the New York Academy of Sciences,1144, 97–112. doi:10.1196/annals.1418.005.
153. Maucksch, C., Vazey, E. M., Gordon, R. J., & Connor, B. (2013). Stem cell-based therapy for Huntington’s disease. Journal of Cellular Biochemistry,114(4), 754–763. doi:10.1002/jcb.24432.
154. Mazumdar, J., O’Brien, W. T., Johnson, R. S., LaManna, J. C., Chavez, J. C., Klein, P. S., & Simon, M. C. (2010). O2 regulates stem cells through Wnt/β-catenin signalling. Nature Cell Biology,12(10), 1007–1013. doi:10.1038/ncb2102.
155. McAvoy, K., Russo, C., Kim, S., Rankin, G., & Sahay, A. (2015). Fluoxetine induces input-specific hippocampal dendritic spine remodeling along the septotemporal axis in adulthood and middle age. Hippocampus,. doi:10.1002/hipo.22464.
156. McEwen, B. S. (1999). Stress and hippocampal plasticity. Annual Review of Neuroscience,22, 105–122. doi:10.1146/annurev.neuro.22.1.105.
157. Mehrotra, S., Lynam, D., Maloney, R., Pawelec, K. M., Tuszynski, M. H., Lee, I., et al. (2010). Time controlled protein release from layer-by-layer assembled multilayer functionalized agarose hydrogels. Advanced Functional Materials,20(2), 247–258. doi:10.1002/adfm.200901172.
158. Menasché, P., Vanneaux, V., Fabreguettes, J.-R., Bel, A., Tosca, L., Garcia, S., et al. (2015). Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: A translational experience. European Heart Journal,36(12), 743–750. doi:10.1093/eurheartj/ehu192.
159. Mendez, I., Sanchez-Pernaute, R., Cooper, O., Viñuela, A., Ferrari, D., Björklund, L., et al. (2005). Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson’s disease. Brain: A Journal of Neurology,128(Pt 7), 1498–1510. doi:10.1093/brain/awh510.
160. Migliore, M. M., Ortiz, R., Dye, S., Campbell, R. B., Amiji, M. M., & Waszczak, B. L. (2014). Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease. Neuroscience,274, 11–23. doi:10.1016/j.neuroscience.2014.05.019.
161. Milosevic, J., Adler, I., Manaenko, A., Schwarz, S. C., Walkinshaw, G., Arend, M., et al. (2009). Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): Relevance in neural progenitor/stem cells. Neurotoxicity Research,15(4), 367–380. doi:10.1007/s12640-009-9043-z.
162. Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., et al. (2004). Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proceedings of the National Academy of Sciences of the United States of America,101(29), 10827–10832. doi:10.1073/pnas.0402141101.
163. Monteggia, L. M., Luikart, B., Barrot, M., Theobold, D., Malkovska, I., Nef, S., et al. (2007). Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biological Psychiatry,61(2), 187–197. doi:10.1016/j.biopsych.2006.03.021.
164. Mu, J., Krafft, P. R., & Zhang, J. H. (2011). Hyperbaric oxygen therapy promotes neurogenesis: Where do we stand? Medical Gas Research,1(1), 14. doi:10.1186/2045-9912-1-14.
165. Mukherjee, A., Raison, M., Sahni, T., Arya, A., Lambert, J., Marois, P., et al. (2014). Intensive rehabilitation combined with HBO2 therapy in children with cerebral palsy: a controlled longitudinal study. Undersea & Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society, Inc, 41(2), 77–85. http://www.ncbi.nlm.nih.gov/pubmed/24851544. Accessed July 29, 2014.
166. Mychaskiw, G. (2010). Hyperbaric oxygen therapy and neurologic disease: the time has come. Undersea & Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society, Inc, 37(2), xi–xiii. http://www.ncbi.nlm.nih.gov/pubmed/20462138. Accessed July 29, 2014.
167. Nair, S. S., Prathibha, P., Syam Das, S., Kavitha, S., & Indira, M. (2015). All trans retinoic acid (ATRA) mediated modulation of N-methyl d-aspartate receptor (NMDAR) and Kruppel like factor 11 (KLF11) expressions in the mitigation of ethanol induced alterations in the brain. Neurochemistry International,83–84, 41–47. doi:10.1016/j.neuint.2015.02.007.
168. Narkilahti, S., Rajala, K., Pihlajamäki, H., Suuronen, R., Hovatta, O., & Skottman, H. (2007). Monitoring and analysis of dynamic growth of human embryonic stem cells: Comparison of automated instrumentation and conventional culturing methods. Biomedical Engineering Online,6, 11. doi:10.1186/1475-925X-6-11.
169. Narvekar, M., Xue, H. Y., & Wong, H. L. (2012). A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). International Journal of Pharmaceutics,436(1–2), 721–731. doi:10.1016/j.ijpharm.2012.07.042.
170. Noisa, P., & Parnpai, R. (2011). Technical challenges in the derivation of human pluripotent cells. Stem cells international,2011, 907961. doi:10.4061/2011/907961.
171. Nunes, M. C., Roy, N. S., Keyoung, H. M., Goodman, R. R., McKhann, G., Jiang, L., et al. (2003). Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nature Medicine,9(4), 439–447. doi:10.1038/nm837.
172. Ormerod, B. K., Palmer, T. D., & Caldwell, M. A. (2008). Neurodegeneration and cell replacement. Philosophical Transactions of the Royal Society of London. Series B, Biological sciences,363(1489), 153–170. doi:10.1098/rstb.2006.2018.
173. Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., et al. (2014). Generation of functional human pancreatic β cells in vitro. Cell,159(2), 428–439. doi:10.1016/j.cell.2014.09.040.
174. Palencia, G., Hernández-Pedro, N., Saavedra-Perez, D., Peña-Curiel, O., Ortiz-Plata, A., Ordoñez, G., et al. (2014). Retinoic acid reduces solvent-induced neuropathy and promotes neural regeneration in mice. Journal of Neuroscience Research,92(8), 1062–1070. doi:10.1002/jnr.23376.
175. Pang, Z., Lu, W., Gao, H., Hu, K., Chen, J., Zhang, C., et al. (2008). Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. Journal of Controlled Release: Official Journal of the Controlled Release Society,128(2), 120–127. doi:10.1016/j.jconrel.2008.03.007.
176. Park, T. I.-H., Monzo, H., Mee, E. W., Bergin, P. S., Teoh, H. H., Montgomery, J. M., et al. (2012). Adult human brain neural progenitor cells (NPCs) and fibroblast-like cells have similar properties in vitro but only NPCs differentiate into neurons. PLoS ONE,7(6), e37742. doi:10.1371/journal.pone.0037742.
177. Paschaki, M., Cammas, L., Muta, Y., Matsuoka, Y., Mak, S.-S., Rataj-Baniowska, M., et al. (2013). Retinoic acid regulates olfactory progenitor cell fate and differentiation. Neural Development,8, 13. doi:10.1186/1749-8104-8-13.
178. Peng, S., Wuu, J., Mufson, E. J., & Fahnestock, M. (2004). Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. Journal of Neuropathology and Experimental Neurology, 63(6), 641–649. http://www.ncbi.nlm.nih.gov/pubmed/15217092. Accessed June 15, 2014.
179. Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E., Bruses, J., Topf, N., et al. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America,101(34), 12543–12548. doi:10.1073/pnas.0404700101.
180. Pettus, E. H., Wright, D. W., Stein, D. G., & Hoffman, S. W. (2005). Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Research,1049(1), 112–119. doi:10.1016/j.brainres.2005.05.004.
181. Pibiri, F., Nelson, M., Guidotti, A., Costa, E., & Pinna, G. (2008). Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. Proceedings of the National Academy of Sciences of the United States of America,105(14), 5567–5572. doi:10.1073/pnas.0801853105.
182. Pillai, A. (2008). Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia. Neuro-Signals,16(2–3), 183–193. doi:10.1159/000111562.
183. Piña-Crespo, J. C., Talantova, M., Cho, E.-G., Soussou, W., Dolatabadi, N., Ryan, S. D., et al. (2012). High-frequency hippocampal oscillations activated by optogenetic stimulation of transplanted human ESC-derived neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,32(45), 15837–15842. doi:10.1523/JNEUROSCI.3735-12.2012.
184. Rangarajan, P., Eng-Ang, L., & Dheen, S. T. (2013). Potential drugs targeting microglia: current knowledge and future prospects. CNS & Neurological Disorders Drug Targets, 12(6), 799–806. http://www.ncbi.nlm.nih.gov/pubmed/24047522. Accessed June 5, 2014.
185. Reubinoff, B. E., Itsykson, P., Turetsky, T., Pera, M. F., Reinhartz, E., Itzik, A., & Ben-Hur, T. (2001). Neural progenitors from human embryonic stem cells. Nature Biotechnology,19(12), 1134–1140. doi:10.1038/nbt1201-1134.
186. Reynolds, B., & Weiss, S. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science,255(5052), 1707–1710. doi:10.1126/science.1553558.
187. Richardson, R. M., Holloway, K. L., Bullock, M. R., Broaddus, W. C., & Fillmore, H. L. (2006). Isolation of neuronal progenitor cells from the adult human neocortex. Acta Neurochirurgica,148(7), 773–777. doi:10.1007/s00701-006-0778-5.
188. Richardson, R. M., Sun, D., & Bullock, M. R. (2007). Neurogenesis after traumatic brain injury. Neurosurgery Clinics of North America, 18(1), 169–181, xi. doi:10.1016/j.nec.2006.10.007.
189. Rockswold, S. B., Rockswold, G. L., & Defillo, A. (2007). Hyperbaric oxygen in traumatic brain injury. Neurological Research,29(2), 162–172. doi:10.1179/016164107X181798.
190. Roof, R. L., Hoffman, S. W., & Stein, D. G. (1997). Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Molecular and Chemical Neuropathology/Sponsored by the International Society for Neurochemistry and the World Federation of Neurology and Research Groups on Neurochemistry and Cerebrospinal Fluid, 31(1), 1–11. http://www.ncbi.nlm.nih.gov/pubmed/9271001. Accessed July 15, 2014.
191. Rossignol, D. A., Rossignol, L. W., Smith, S., Schneider, C., Logerquist, S., Usman, A., et al. (2009). Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics,9, 21. doi:10.1186/1471-2431-9-21.
192. Saarelainen, T., Hendolin, P., Lucas, G., Koponen, E., Sairanen, M., MacDonald, E., et al. (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 23(1), 349–357. http://www.ncbi.nlm.nih.gov/pubmed/12514234. Accessed July 7, 2014.
193. Sajadi, A., Bensadoun, J.-C., Schneider, B. L., Lo Bianco, C., & Aebischer, P. (2006). Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease. Neurobiology of Disease,22(1), 119–129. doi:10.1016/j.nbd.2005.10.006.
194. Sakane, T., & Pardridge, W. M. (1997). Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity. Pharmaceutical Research, 14(8), 1085–1091. http://www.ncbi.nlm.nih.gov/pubmed/9279893. Accessed September 22, 2014.
195. Sampanthavivat, M., Singkhwa, W., Chaiyakul, T., Karoonyawanich, S., & Ajpru, H. (2012). Hyperbaric oxygen in the treatment of childhood autism: a randomised controlled trial. Diving and Hyperbaric Medicine: the Journal of the South Pacific Underwater Medicine Society, 42(3), 128–133. http://www.ncbi.nlm.nih.gov/pubmed/22987458. Accessed July 24, 2014.
196. Sanai, N., Tramontin, A. D., Quiñones-Hinojosa, A., Barbaro, N. M., Gupta, N., Kunwar, S., et al. (2004). Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature,427(6976), 740–744. doi:10.1038/nature02301.
197. Sandhir, R., Yadav, A., Mehrotra, A., Sunkaria, A., Singh, A., & Sharma, S. (2014). Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington’s disease. NeuroMolecular Medicine,16(1), 106–118. doi:10.1007/s12017-013-8261-y.
198. Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S., Murakami, A., Sethi, G., et al. (2007). Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis,28(8), 1765–1773. doi:10.1093/carcin/bgm123.
199. Santos, T., Ferreira, R., Maia, J., Agasse, F., Xapelli, S., Cortes, L., et al. (2012). Polymeric nanoparticles to control the differentiation of neural stem cells in the subventricular zone of the brain. ACS Nano,6(12), 10463–10474. doi:10.1021/nn304541h.
200. Schulz, T. C., Young, H. Y., Agulnick, A. D., Babin, M. J., Baetge, E. E., Bang, A. G., et al. (2012). A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS ONE,7(5), e37004. doi:10.1371/journal.pone.0037004.
201. Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., et al. (2012). Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet,379(9817), 713–720. doi:10.1016/S0140-6736(12)60028-2.
202. Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., et al. (2014). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: Follow-up of two open-label phase 1/2 studies. The Lancet,385(9967), 509–516. doi:10.1016/S0140-6736(14)61376-3.
203. Shin, H. Y., Kim, J. H., Phi, J. H., Park, C.-K., Kim, J. E., Kim, J.-H., et al. (2008). Endogenous neurogenesis and neovascularization in the neocortex of the rat after focal cerebral ischemia. Journal of Neuroscience Research,86(2), 356–367. doi:10.1002/jnr.21494.
204. Shirakura, M., Inoue, M., Fujikawa, S., Washizawa, K., Komaba, S., Maeda, M., et al. (2004). Postischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils. Gene Therapy,11(9), 784–790. doi:10.1038/sj.gt.3302224.
205. Simon, A., Allais, D. P., Duroux, J. L., Basly, J. P., Durand-Fontanier, S., & Delage, C. (1998). Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Letters, 129(1), 111–116. http://www.ncbi.nlm.nih.gov/pubmed/9714342. Accessed July 29, 2014.
206. Skaper, S. D. (2012). The neurotrophin family of neurotrophic factors: an overview. Methods in Molecular Biology (Clifton, N.J.), 846, 1–12. doi:10.1007/978-1-61779-536-7_1.
207. Sommerfeld, M. T., Schweigreiter, R., Barde, Y. A., & Hoppe, E. (2000). Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB. The Journal of Biological Chemistry, 275(12), 8982–8990. http://www.ncbi.nlm.nih.gov/pubmed/10722747. Accessed September 14, 2014.
208. Squinto, S. P., Stitt, T. N., Aldrich, T. H., Davis, S., Bianco, S. M., Radziejewski, C., et al. (1991). trkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell, 65(5), 885–893. http://www.ncbi.nlm.nih.gov/pubmed/1710174. Accessed June 29, 2014.
209. Stachowiak, E. K., Roy, I., Lee, Y.-W., Capacchietti, M., Aletta, J. M., Prasad, P. N., & Stachowiak, M. K. (2009). Targeting novel integrative nuclear FGFR1 signaling by nanoparticle-mediated gene transfer stimulates neurogenesis in the adult brain. Integrative Biology: Quantitative Biosciences from Nano to Macro,1(5–6), 394–403. doi:10.1039/b902617g.
210. Stankowski, J. N., & Gupta, R. (2011). Therapeutic targets for neuroprotection in acute ischemic stroke: Lost in translation? Antioxidants & Redox Signaling,14(10), 1841–1851. doi:10.1089/ars.2010.3292.
211. Stavridis, M. P., Collins, B. J., & Storey, K. G. (2010). Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation. Development (Cambridge, England),137(6), 881–890. doi:10.1242/dev.043117.
212. Steiner, B., Wolf, S., & Kempermann, G. (2006). Adult neurogenesis and neurodegenerative disease. Regenerative Medicine,1(1), 15–28. doi:10.2217/17460751.1.1.15.
213. Sumanont, Y., Murakami, Y., Tohda, M., Vajragupta, O., Watanabe, H., & Matsumoto, K. (2007). Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus. Biological & Pharmaceutical Bulletin, 30(9), 1732–1739. http://www.ncbi.nlm.nih.gov/pubmed/17827730. Accessed July 10, 2014.
214. Suri, D., & Vaidya, V. A. (2013). Glucocorticoid regulation of brain-derived neurotrophic factor: Relevance to hippocampal structural and functional plasticity. Neuroscience,239, 196–213. doi:10.1016/j.neuroscience.2012.08.065.
215. Tachibana, M., Amato, P., Sparman, M., Gutierrez, N. M., Tippner-Hedges, R., Ma, H., et al. (2013). Human embryonic stem cells derived by somatic cell nuclear transfer. Cell,153(6), 1228–1238. doi:10.1016/j.cell.2013.05.006.
216. Takahashi, J., Palmer, T. D., & Gage, F. H. (1999). Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures. Journal of Neurobiology, 38(1), 65–81. http://www.ncbi.nlm.nih.gov/pubmed/10027563. Accessed July 8, 2014.
217. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell,131(5), 861–872. doi:10.1016/j.cell.2007.11.019.
218. Tan, J., Wang, Y., Yip, X., Glynn, F., Shepherd, R. K., & Caruso, F. (2012). Nanoporous peptide particles for encapsulating and releasing neurotrophic factors in an animal model of neurodegeneration. Advanced Materials (Deerfield Beach, Fla.),24(25), 3362–3366. doi:10.1002/adma.201200634.
219. Tan, J., Shi, J., Shi, G., Liu, Y., Liu, X., Wang, C., et al. (2013). Changes in compressed neurons from dogs with acute and severe cauda equina constrictions following intrathecal injection of brain-derived neurotrophic factor-conjugated polymer nanoparticles. Neural Regeneration Research,8(3), 233–243. doi:10.3969/j.issn.1673-5374.2013.03.005.
220. Thapa, A., Vernon, B. C., De la Peña, K., Soliz, G., Moreno, H. A., López, G. P., & Chi, E. Y. (2013). Membrane-mediated neuroprotection by curcumin from amyloid-β-peptide-induced toxicity. Langmuir: The ACS Journal of Surfaces and Colloids,29(37), 11713–11723. doi:10.1021/la4020459.
221. Theofilopoulos, S., Goggi, J., Riaz, S. S., Jauniaux, E., Stern, G. M., & Bradford, H. F. (2001). Parallel induction of the formation of dopamine and its metabolites with induction of tyrosine hydroxylase expression in foetal rat and human cerebral cortical cells by brain-derived neurotrophic factor and glial-cell derived neurotrophic factor. Brain Research. Developmental Brain Research,127(2), 111–122. doi:10.1016/S0165-3806(01)00125-0.
222. Thoenen, H. (1995). Neurotrophins and neuronal plasticity. Science (New York, N.Y.), 270(5236), 593–598. http://www.ncbi.nlm.nih.gov/pubmed/7570017. Accessed June 29, 2014.
223. Tian, X., Wang, J., Dai, J., Yang, L., Zhang, L., Shen, S., & Huang, P. (2012). Hyperbaric oxygen and Ginkgo Biloba extract inhibit Aβ25-35-induced toxicity and oxidative stress in vivo: A potential role in Alzheimer’s disease. The International Journal of Neuroscience,122(10), 563–569. doi:10.3109/00207454.2012.690797.
224. Tiwari, S. S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., et al. (2014). Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer’s disease model via canonical Wnt/β-catenin pathway. ACS Nano,8(1), 76–103. doi:10.1021/nn405077y.
225. Tripanichkul, W., & Jaroensuppaperch, E.-O. (2013). Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice. European Review for Medical and Pharmacological Sciences, 17(10), 1360–1368. http://www.ncbi.nlm.nih.gov/pubmed/23740450. Accessed July 10, 2014.
226. Trounson, A. (2006). The production and directed differentiation of human embryonic stem cells. Endocrine Reviews,27(2), 208–219. doi:10.1210/er.2005-0016.
227. Tsai, S.-J. (2006). TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism. Medical Hypotheses,66(1), 173–175. doi:10.1016/j.mehy.2005.05.033.
228. Tsai, Y.-M., Chien, C.-F., Lin, L.-C., & Tsai, T.-H. (2011). Curcumin and its nano-formulation: The kinetics of tissue distribution and blood-brain barrier penetration. International Journal of Pharmaceutics,416(1), 331–338. doi:10.1016/j.ijpharm.2011.06.030.
229. Uchida, K., Momiyama, T., Okano, H., Yuzaki, M., Koizumi, A., Mine, Y., & Kawase, T. (2005). Potential functional neural repair with grafted neural stem cells of early embryonic neuroepithelial origin. Neuroscience Research,52(3), 276–286. doi:10.1016/j.neures.2005.03.015.
230. Uzun, G., Subhani, D., & Amor, S. (2010). Trophic factors and stem cells for promoting recovery in stroke. Journal of Vascular and Interventional Neurology, 3(1), 3–12. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3317290&tool=pmcentrez&rendertype=abstract. Accessed July 7, 2014.
231. Uzunova, V., Sheline, Y., Davis, J. M., Rasmusson, A., Uzunov, D. P., Costa, E., et al. (1998). Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proceedings of the National Academy of Sciences of the United States of America, 95(6), 3239–3244. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19726&tool=pmcentrez&rendertype=abstract. Accessed July 15, 2014.
232. Van Kampen, J. M., Baranowski, D., & Kay, D. G. (2014). Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson’s disease. PLoS ONE,9(5), e97032. doi:10.1371/journal.pone.0097032.
233. Wakade, C. G., Mahadik, S. P., Waller, J. L., & Chiu, F.-C. (2002). Atypical neuroleptics stimulate neurogenesis in adult rat brain. Journal of Neuroscience Research,69(1), 72–79. doi:10.1002/jnr.10281.
234. Wang, L.-J., Lu, Y.-Y., Muramatsu, S., Ikeguchi, K., Fujimoto, K., Okada, T., et al. (2002). Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,22(16), 6920–6928.
235. Wang, Q., Sun, A. Y., Simonyi, A., Jensen, M. D., Shelat, P. B., Rottinghaus, G. E., et al. (2005a). Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. Journal of Neuroscience Research,82(1), 138–148. doi:10.1002/jnr.20610.
236. Wang, T.-W., Zhang, H., & Parent, J. M. (2005b). Retinoic acid regulates postnatal neurogenesis in the murine subventricular zone-olfactory bulb pathway. Development (Cambridge, England),132(12), 2721–2732. doi:10.1242/dev.01867.
237. Wang, X.-L., Yang, Y.-J., Xie, M., Yu, X.-H., Liu, C.-T., & Wang, X. (2007a). Proliferation of neural stem cells correlates with Wnt-3 protein in hypoxic-ischemic neonate rats after hyperbaric oxygen therapy. NeuroReport,18(16), 1753–1756. doi:10.1097/WNR.0b013e3282f0ec09.
238. Wang, Y., Mao, X. O., Xie, L., Banwait, S., Marti, H. H., Greenberg, D. A., & Jin, K. (2007b). Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience,27(2), 304–307. doi:10.1523/JNEUROSCI.4433-06.2007.
239. Wang, X.-L., Yang, Y.-J., Xie, M., Yu, X.-H., & Wang, Q.-H. (2009). [Hyperbaric oxygen promotes the migration and differentiation of endogenous neural stem cells in neonatal rats with hypoxic-ischemic brain damage]. Zhongguo dang dai er ke za zhi = Chinese Journal of Contemporary Pediatrics, 11(9), 749–52. http://www.ncbi.nlm.nih.gov/pubmed/19755026. Accessed July 24, 2014.
240. Webster, N. J. G., & Pirrung, M. C. (2008). Small molecule activators of the Trk receptors for neuroprotection. BMC Neuroscience, 9 Suppl 2(Suppl 2), S1. doi:10.1186/1471-2202-9-S2-S1.
241. Weissmiller, A. M., & Wu, C. (2012). Current advances in using neurotrophic factors to treat neurodegenerative disorders. Translational Neurodegeneration,1(1), 14. doi:10.1186/2047-9158-1-14.
242. Wernig, M., Zhao, J.-P., Pruszak, J., Hedlund, E., Fu, D., Soldner, F., et al. (2008). Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson’s disease. Proceedings of the National Academy of Sciences of the United States of America,105(15), 5856–5861. doi:10.1073/pnas.0801677105.
243. Wichterle, H., Lieberam, I., Porter, J. A., & Jessell, T. M. (2002). Directed differentiation of embryonic stem cells into motor neurons. Cell, 110(3), 385–97. http://www.ncbi.nlm.nih.gov/pubmed/12176325. Accessed May 27, 2014.
244. Wu, D. (2005). Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx: the journal of the American Society for Experimental NeuroTherapeutics,2(1), 120–128. doi:10.1602/neurorx.2.1.120.
245. Xia, C.-F., Boado, R. J., Zhang, Y., Chu, C., & Pardridge, W. M. (2008). Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson’s disease with Trojan horse liposomes and a tyrosine hydroxylase promoter. The Journal of Gene Medicine,10(3), 306–315. doi:10.1002/jgm.1152.
246. Xie, Y., Ye, L., Zhang, X., Cui, W., Lou, J., Nagai, T., & Hou, X. (2005). Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: In vitro and in vivo studies. Journal of Controlled Release: Official Journal of the Controlled Release Society,105(1–2), 106–119. doi:10.1016/j.jconrel.2005.03.005.
247. Yanamoto, H., Nagata, I., Sakata, M., Zhang, Z., Tohnai, N., Sakai, H., & Kikuchi, H. (2000). Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor. Brain Research, 859(2), 240–248. http://www.ncbi.nlm.nih.gov/pubmed/10719070. Accessed July 1, 2014.
248. Yang, K., Clifton, G. L., & Hayes, R. L. (1997). Gene therapy for central nervous system injury: the use of cationic liposomes: an invited review. Journal of Neurotrauma, 14(5), 281–297. http://www.ncbi.nlm.nih.gov/pubmed/9199395. Accessed September 21, 2014.
249. Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., et al. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. The Journal of biological chemistry,280(7), 5892–5901. doi:10.1074/jbc.M404751200.
250. Yang, K.-Y., Lin, L.-C., Tseng, T.-Y., Wang, S.-C., & Tsai, T.-H. (2007). Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences,853(1–2), 183–189. doi:10.1016/j.jchromb.2007.03.010.
251. Yin, D., & Zhang, J. H. (2005). Delayed and multiple hyperbaric oxygen treatments expand therapeutic window in rat focal cerebral ischemic model. Neurocritical Care,2(2), 206–211. doi:10.1385/NCC:2:2:206.
252. Yin, D., Zhou, C., Kusaka, I., Calvert, J. W., Parent, A. D., Nanda, A., & Zhang, J. H. (2003). Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism,23(7), 855–864. doi:10.1097/01.WCB.0000073946.29308.55.
253. Yoo, M., Joung, I., Han, A. M., Yoon, H. H., & Kwon, Y. K. (2007). Distinct effect of neurotrophins delivered simultaneously by an adenoviral vector on neurite outgrowth of neural precursor cells from different regions of the brain. Journal of Microbiology and Biotechnology, 17(12), 2033–2041. http://www.ncbi.nlm.nih.gov/pubmed/18167452. Accessed June 17, 2014.
254. Yurek, D. M., Fletcher, A. M., Smith, G. M., Seroogy, K. B., Ziady, A. G., Molter, J., et al. (2009). Long-term transgene expression in the central nervous system using DNA nanoparticles. Molecular Therapy: The Journal of the American Society of Gene Therapy,17(4), 641–650. doi:10.1038/mt.2009.2.
255. Zeng, X., Chen, J., Deng, X., Liu, Y., Rao, M. S., Cadet, J.-L., & Freed, W. J. (2006). An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP + toxicity and GDNF neuroprotection. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology,31(12), 2708–2715. doi:10.1038/sj.npp.1301125.
256. Zhang, S. C., Wernig, M., Duncan, I. D., Brüstle, O., & Thomson, J. A. (2001). In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nature Biotechnology,19(12), 1129–1133. doi:10.1038/nbt1201-1129.
257. Zhang, T., Yang, Q.-W., Wang, S.-N., Wang, J.-Z., Wang, Q., Wang, Y., & Luo, Y.-J. (2010). Hyperbaric oxygen therapy improves neurogenesis and brain blood supply in piriform cortex in rats with vascular dementia. Brain Injury: [BI],24(11), 1350–1357. doi:10.3109/02699052.2010.504525.
258. Zhang, X.-Y., Yang, Y.-J., Xu, P.-R., Zheng, X.-R., Wang, Q.-H., Chen, C.-F., & Yao, Y. (2011a). The role of β-catenin signaling pathway on proliferation of rats neural stem cells after hyperbaric oxygen therapy in vitro. Cellular and Molecular Neurobiology,31(1), 101–109. doi:10.1007/s10571-010-9559-z.
259. Zhang, Y., Wang, J., Chen, G., Fan, D., & Deng, M. (2011b). Inhibition of Sirt1 promotes neural progenitors toward motoneuron differentiation from human embryonic stem cells. Biochemical and Biophysical Research Communications,404(2), 610–614. doi:10.1016/j.bbrc.2010.12.014.
260. Zhang, F., Kang, Z., Li, W., Xiao, Z., & Zhou, X. (2012). Roles of brain-derived neurotrophic factor/tropomyosin-related kinase B (BDNF/TrkB) signalling in Alzheimer’s disease. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia,19(7), 946–949. doi:10.1016/j.jocn.2011.12.022.
261. Zhang, E., Shen, J., & So, K. F. (2014). Chinese Traditional Medicine and Adult Neurogenesis in the Hippocampus. Journal of Traditional and Complementary Medicine,4(2), 77–81. doi:10.4103/2225-4110.130372.
262. Zhao, C., Deng, W., & Gage, F. H. (2008). Mechanisms and functional implications of adult neurogenesis. Cell,132(4), 645–660. doi:10.1016/j.cell.2008.01.033.
263. Zhu, D. Y., Lau, L., Liu, S. H., Wei, J. S., & Lu, Y. M. (2004). Activation of cAMP-response-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proceedings of the National Academy of Sciences of the United States of America,101(25), 9453–9457. doi:10.1073/pnas.0401063101.
264. Zhu, G., Chen, G., Shi, L., Feng, J., Wang, Y., Ye, C., et al. (2014). PEGylated rhFGF-2 conveys long-term neuroprotection and improves neuronal function in a rat model of Parkinson’s disease. Molecular Neurobiology,. doi:10.1007/s12035-014-8750-5.
265. Zuccato, C., & Cattaneo, E. (2007). Role of brain-derived neurotrophic factor in Huntington’s disease. Progress in Neurobiology,81(5–6), 294–330. doi:10.1016/j.pneurobio.2007.01.003.